Market Capitalization of Brooks Laboratories (BROOKS)
As of April 15, 2026, Brooks Laboratories (BROOKS) market capitalisation is ₹137.30 Cr ($15.26M), with 1.91 Cr shares outstanding at a current price of ₹72.07 on NSE, ranking 2864 out of 5362 companies by market cap in our screener. Brooks Laboratories operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Brooks Laboratories screener.
Market Cap History of Brooks Laboratories (Last 10 Years)
BROOKS market capitalisation from year-end NSE closing prices over the last 10 years. Read BROOKS ex-dividend dates for the complete payout history and dividend yield track record.
End of Year Market Cap History — Brooks Laboratories
BROOKS year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Analyse BROOKS shareholder distribution to track promoter, FII and institutional holdings.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹137.30 Cr
$15.26M USD
|
₹72.07 | NSE | -10.07% |
| 2025 |
₹152.67 Cr
$16.96M USD
|
₹80.14 | NSE | -56.67% |
| 2024 |
₹352.35 Cr
$39.15M USD
|
₹184.95 | BSE | +28.39% |
| 2023 |
₹274.43 Cr
$30.49M USD
|
₹144.05 | BSE | +33.02% |
| 2022 |
₹206.30 Cr
$22.92M USD
|
₹108.29 | BSE | +9.57% |
| 2021 |
₹188.28 Cr
$20.92M USD
|
₹98.83 | BSE | +50.17% |
| 2020 |
₹125.37 Cr
$13.93M USD
|
₹65.81 | BSE | +128.35% |
| 2019 |
₹54.90 Cr
$6.10M USD
|
₹28.82 | BSE | -51.85% |
| 2018 |
₹114.04 Cr
$12.67M USD
|
₹59.86 | BSE | -46.89% |
| 2017 |
₹214.70 Cr
$23.86M USD
|
₹112.70 | BSE | -14.94% |
| 2016 |
₹252.42 Cr
$28.05M USD
|
₹132.50 | BSE | +45.03% |
| 2015 |
₹174.05 Cr
$19.34M USD
|
₹91.36 | BSE | +105.26% |
| 2014 |
₹84.80 Cr
$9.42M USD
|
₹44.51 | BSE | +125.25% |
| 2013 |
₹37.64 Cr
$4.18M USD
|
₹19.76 | BSE | -10.10% |
| 2012 |
₹41.87 Cr
$4.65M USD
|
₹21.98 | BSE | +73.34% |
| 2011 |
₹24.16 Cr
$2.68M USD
|
₹12.68 | BSE | - |